SCHEMBL24273692

SCHEMBL24273692

CC1CN(C(C)C)CC(C)C1N

nearest known ligand 0.00

⚠ Novel chemotype — no close known analogue (best Tanimoto < 0.3). Unexplored chemical space relative to ChEMBL.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL14925919 0.83 DRD4 (0.32)
SCHEMBL14925923 0.83 DRD4 (0.32)
SCHEMBL10129414 0.83 DRD4 (0.32)
SCHEMBL14925920 0.83 DRD4 (0.32)
SCHEMBL2737431 0.82 DRD4 (0.31)
SCHEMBL2737418 0.82 DRD4 (0.31)
SCHEMBL2737408 0.82 DRD4 (0.31)
SCHEMBL2737379 0.82 DRD4 (0.31)
SCHEMBL2737417 0.82 DRD4 (0.31)
SCHEMBL22623061 0.76

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20240238265-A1 ADAMANTANE AMIDES AND THIOAMIDES FOR THE TREATMENT OF EBOLAVIRUS INFECTION ARISAN THERAPEUTICS INC. (US) 2024-07-18 US disclosed
WO-2021262426-A9 ADAMANTANE AMIDES AND THIOAMIDES FOR THE TREATMENT OF EBOLAVIRUS INFECTION ARISAN THERAPEUTICS INC. (US) 2022-03-17 WO disclosed